Revised SPCs: Keppra (levetiracetam) products

SPC now warns that as with other antiepileptics, levetiracetam may rarely exacerbate seizure frequency/severity. This paradoxical effect was mostly reported within 1st month after start of treatment or increase of dose and was reversible upon drug discontinuation or dose decrease

electronic Medicines compendium